These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23022476)

  • 1. Functional inactivation of Rb sensitizes cancer cells to TSC2 inactivation induced cell death.
    Danos AM; Liao Y; Li X; Du W
    Cancer Lett; 2013 Jan; 328(1):36-43. PubMed ID: 23022476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Rb mutant cancers by inactivating TSC2.
    Searle JS; Li B; Du W
    Oncotarget; 2010 Jul; 1(3):228-32. PubMed ID: 20706560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific killing of Rb mutant cancer cells by inactivating TSC2.
    Li B; Gordon GM; Du CH; Xu J; Du W
    Cancer Cell; 2010 May; 17(5):469-80. PubMed ID: 20478529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma.
    Lu KH; Wu W; Dave B; Slomovitz BM; Burke TW; Munsell MF; Broaddus RR; Walker CL
    Clin Cancer Res; 2008 May; 14(9):2543-50. PubMed ID: 18451215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
    Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential IKK/NF-κB Activity Is Mediated by TSC2 through mTORC1 in PTEN-Null Prostate Cancer and Tuberous Sclerosis Complex Tumor Cells.
    Gao Y; Gartenhaus RB; Lapidus RG; Hussain A; Zhang Y; Wang X; Dan HC
    Mol Cancer Res; 2015 Dec; 13(12):1602-14. PubMed ID: 26374334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.
    Chen W; Pan Y; Wang S; Liu Y; Chen G; Zhou L; Ni W; Wang A; Lu Y
    BMC Cancer; 2017 Jan; 17(1):34. PubMed ID: 28061838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
    Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
    Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
    Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
    Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.
    Soucek T; Yeung RS; Hengstschläger M
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15653-8. PubMed ID: 9861025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
    Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
    Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions.
    Kaper F; Dornhoefer N; Giaccia AJ
    Cancer Res; 2006 Feb; 66(3):1561-9. PubMed ID: 16452213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1.
    Radu A; Neubauer V; Akagi T; Hanafusa H; Georgescu MM
    Mol Cell Biol; 2003 Sep; 23(17):6139-49. PubMed ID: 12917336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA‑93‑5p promotes the progression of human retinoblastoma by regulating the PTEN/PI3K/AKT signaling pathway.
    Cao Y; Xia F; Wang P; Gao M
    Mol Med Rep; 2018 Dec; 18(6):5807-5814. PubMed ID: 30365088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
    Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
    J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Rb inactivation in cancers by synthetic lethality.
    Gordon GM; Du W
    Am J Cancer Res; 2011 Jun; 1(6):773-86. PubMed ID: 21814623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase.
    Soucek T; Pusch O; Wienecke R; DeClue JE; Hengstschläger M
    J Biol Chem; 1997 Nov; 272(46):29301-8. PubMed ID: 9361010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.
    Chakraborty S; Mohiyuddin SM; Gopinath KS; Kumar A
    BMC Cancer; 2008 Jun; 8():163. PubMed ID: 18538015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSC2 deficiency increases PTEN via HIF1alpha.
    Mahimainathan L; Ghosh-Choudhury N; Venkatesan B; Das F; Mandal CC; Dey N; Habib SL; Kasinath BS; Abboud HE; Ghosh Choudhury G
    J Biol Chem; 2009 Oct; 284(41):27790-27798. PubMed ID: 19648120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas.
    Pérez de Castro IP; Malumbres M; Santos J; Pellicer A; Fernández-Piqueras J
    Carcinogenesis; 1999 Sep; 20(9):1675-82. PubMed ID: 10469610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.